Sleep aids in the consolidation of memory and also plays a key role in regulating emotions. Extinction is a form of emotional memory that promotes emotion regulation by inhibiting the expression of conditioned fear. Using a validated 2-day human protocol, we propose to compare extinction memory between persons with Primary Insomnia and normally sleeping controls to test the main hypothesis that those with insomnia will display poorer extinction memory. Conditioned fear will be established to two colors as conditioned stimuli (CS+) using a mild electric shock as an unconditioned stimulus (US) and skin conductance response (SCR) as the conditioned response (CR). A third color never paired with a shock (CS-) will confirm differential conditioning. Fear of one color (CS+E) will then be extinguished by its repeated presentation without the US. After 24 h, memory for this extinction learning as well as the conditioned fear memory for the unextinguished CS+ (CS+U) will be tested. The accompanying neural responses will be measured at each stage of this protocol (fear conditioning, extinction learning, extinction recall) using functional magnetic resonance imaging (fMRI). Sleep physiology will be measured using ambulatory polysomnography (PSG) on an acclimation night, a baseline night and on the night that will intervene between the day when conditioning and extinction are learned and when they are recalled 24 h later. Correlations of extinction memory performance with sleep physiology will be examined among sleep quality measures (e.g., sleep efficiency) as well as sleep architectural measures (e.g., sleep stage percentages) and measures specific to rapid eye movement (REM) sleep (e.g. REM continuity). It is hypothesized that extinction memory (the degree to which SCR to the CS+E remains suppressed after 24 h) will be poorer in insomniacs. Additionally, it is hypothesized that the degree to which extinction recall generalizes (i.e., the degree to which SCR to the CS+U as well as to the CS+E is reduced) will be greater in controls versus insomniacs. It is also hypothesized that, in insomniacs versus controls during extinction recall, the neural structures whose activity has been associated with extinction learning and memory (ventromedial prefrontal cortex and hippocampus) will be hypoactivated and those associated with the expression of conditioned fear (amygdala and dorsal anterior cingulate cortex) will be hyperactivated. Lastly, it is hypothesized that, in insomniacs, extinction memory will correlate positively with sleep quality as well as with the integrity of sleep architecture, especially during REM sleep, across the night intervening between extinction learning and extinction recall.

Public Health Relevance

Identification of an extinction memory deficit in primary insomnia will reveal a neurobiological basis for the high co-morbidity of sleep disturbance and neuropsychiatric disorders. If an extinction deficit is a shared biomarker between primary insomnia and anxiety disorders, cognitive-behavioral treatment strategies can be developed that more effectively address both sleep and anxiety symptoms in those disorders for which insomnia is frequently co-morbid such as posttraumatic stress disorder and generalized anxiety disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21MH101567-01A1
Application #
8699371
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Muehrer, Peter R
Project Start
2014-04-07
Project End
2016-03-31
Budget Start
2014-04-07
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$246,200
Indirect Cost
$96,200
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Carpenter, Joseph K; Andrews, Leigh A; Witcraft, Sara M et al. (2018) Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depress Anxiety 35:502-514
Fang, Angela; Treadway, Michael T; Hofmann, Stefan G (2017) Working hard for oneself or others: Effects of oxytocin on reward motivation in social anxiety disorder. Biol Psychol 127:157-162
Hofmann, Stefan G; Curtiss, Joshua; Carpenter, Joseph K et al. (2017) Effect of treatments for depression on quality of life: a meta-analysis. Cogn Behav Ther 46:265-286
Pace-Schott, Edward F; Zimmerman, Jared P; Bottary, Ryan M et al. (2017) Resting state functional connectivity in primary insomnia, generalized anxiety disorder and controls. Psychiatry Res Neuroimaging 265:26-34
Furukawa, Toshi A; Weitz, Erica S; Tanaka, Shiro et al. (2017) Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry 210:190-196
Hofmann, Stefan G (2016) Schrödinger's Cat and d-Cycloserine to Augment Exposure Therapy-Both Are Alive and Dead. JAMA Psychiatry 73:771-2
Hofmann, Stefan G; Curtiss, Joshua; McNally, Richard J (2016) A Complex Network Perspective on Clinical Science. Perspect Psychol Sci 11:597-605
Hofmann, Stefan G; Carpenter, Joseph K; Curtiss, Joshua (2016) Interpersonal Emotion Regulation Questionnaire (IERQ): Scale Development and Psychometric Characteristics. Cognit Ther Res 40:341-356
Hofmann, Stefan G (2016) Psychodynamic therapy: a poorly defined concept with questionable evidence. Evid Based Ment Health 19:63
Lin, Muyu; Hofmann, Stefan G; Qian, Mingyi et al. (2016) Attention allocation in social anxiety during a speech. Cogn Emot 30:1122-36

Showing the most recent 10 out of 18 publications